Over a 4-month period, protection with the Novavax vaccine was stable against symptomatic COVID infection.
The company said a combo vaccine could streamline immunization for consumers and health providers and make it easier for people to follow public health recommendations.
The report spells out the complex issues that drove its policies, along with some data gaps officials encountered.
The study is based on heart attack patients seen at Ocean University Medical Center in New Jersey.
The proportion of kindergarteners not up to date with vaccinations rose from 6% in 2019 to 7% in 2020, then fell to 6.01% in 2021.
Trust in physicians and science was associated with not using the treatments.
The first phase of work focuses on an antibody that broadly protects against circulating SARS-CoV-2 variants.
Overall, SARS-CoV-2–associated sepsis was present in 28.2% of patients admitted with SARS-CoV-2.
Median SARS-CoV-2 viral loads, as measured by polymerase chain reaction cycle threshold and antigen concentrations, rose from symptom onset, peaking on the fourth or fifth day of symptoms.
However, most parents said they didn't intend to have their children vaccinated.
Authors compared symptoms among patients following confirmed COVID-19 to produce a list of 89 symptoms and the 30 most common symptoms.
An infectious disease (influenza and pneumonia) was last in the top 5 leading causes of death in 1970.
The UK has detected sporadic cases across most of the country in people who no travel history.
Four to 6 months after a fourth dose, immunoglobulin G levels had regressed to three-dose levels.
However, two early indicators--emergency department visits and test positivity--declined compared to a week ago.
After adjustment, remdesivir was tied to significantly lower in-hospital death rates at both 14 and 28 days.
Black residents had significantly lower access to COVID-19 therapeutic drugs.
Twenty-one percent had PCC-related respiratory problems, and 60% said they experienced fatigue.
In a few days, Americans can go online to order more free tests by mail from the federal government.
Goals include identifying best practices for treating long COVID and increasing access to quality care.
In people who had previously tested positive for SARS-CoV-2, the prevalence of long-term symptoms varied from 26.9% to 64.1%.
The authors said Paxlovid and molnupiravir 'probably' improve outcomes for outpatients with mild to moderate illness.
Sixteen cytokines and chemokines were significantly decreased after vaccination.
But the authors caution that watch histories substantially affect video recommendations, complicating the picture.
The team will collect more than 20,000 samples from wildlife such as eastern chipmunks, gray squirrels, and raccoons.